Global Angiography Equipment Market – Industry analysis and forecast (2019 to 2026) – by Product, Procedure, Technology, Indication, Application, and End-User.

Global Angiography Equipment Market was valued at USD 9.75 billion in 2019, and is estimated to grow at a CAGR of XX% from 2019 to 2026. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. Global Angiography Equipment Market , By Application Angiography is a minimally invasive technique which is utilized to view the blood vessels in the body. Currently, technological advancements in interventional radiology have led to the development of OCT-angiography, MRI-angiography, and digital flat panel contrivances, which are expected to drive the market magnification during the analysis period. The growth in Global Angiography Equipment Market  is attributed to the high predominance of cancer and cardiovascular diseases, growing geriatric population, and higher approvals for advanced angiography devices. Moreover, techniques, research discoveries, better disease awareness, an increasing number of angiography procedures and growing government and public-private investments are certain other key drivers to boost the Global Angiography Equipment Market . Global Angiography Equipment Market device is segmented by product, procedure, technology, indication, application, and end-user. Global Angiography Equipment Market device have the predominately usage in hospital, clinics, diagnostic and imaging centers and research Institutes laboratories. Europe dominated the Global Angiography Equipment Market in 2017. The sizably voluminous quota of the European market can be attributed to factors such as the high prevalence of diseases such as cancer and CVD. The more expeditious and more facile product approbation process in the region, the astronomically immense number of perpetual research activities, growing regime and public-private investments. In addition to this, incrementing number of vigilance programs, and elevating adoption of angiography contrivances due to an astronomically immense number of angiography procedures are also performed in European countries further boosting the overall growth of Global Angiography Equipment Market. The major players in the Global Angiography Equipment Market device are GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Canon Corporation (Japan), Boston Scientific Corporation (US), and Cordis (a Cardinal Health Company, US). Other players in this market include Shimadzu Corporation (Japan), Medtronic (Ireland), Angiodynamics (US), B. Braun Melsungen (Germany), and Abbott Laboratories (US). The objective of the report is to present comprehensive Global Angiography Equipment Market  including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Angiography Equipment Market  North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the   North America for Asia Pacific   size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the   North America for Asia Pacific make the report investor’s guide. The years that have been considered for the study are: • Base year – 2017 • Estimated year – 2018 • Forecast period – 2018 to 2026 Market Key Segment:

 By Product

o Angiography Equipment Solutions  Angiography Systems  Angiography Catheters  Angiography Contrast Media  Vascular Closure Devices (VCDs)  Angiography Balloons  Angiography Guidewires  Angiography Accessories By Technology o X-Ray Angiography  Image Intensifiers  Flat-panel Detectors o CT Angiography o MR Angiography o Other Angiography Technologies

 By Procedure

o Coronary Angiography o Endovascular Angiography o Neuroangiography o Onco-angiography o Other Angiography Procedures

 By Indication

o Coronary Artery Disease o Valvular Heart Disease o Congenital Heart Disease o Congestive Heart Failure o Other Indications

 By Application

o Diagnostics o Therapeutics

 By End User

o Hospitals and Clinics o Diagnostic and Imaging Centers o Research Institutes

 By Region

North America • U.S • Canada Europe • Germany • France • UK • Italy • Spain • Russia • Rest of Europe Asia Pacific • Japan • China • India • South Korea • Australia • Rest of Asia Pacific Rest of the World (ROW) • Middle-East • Africa • Latin America Key Players • GE Healthcare (US), • Koninklijke Philips N.V. (Netherlands) • Siemens Healthineers (Germany) • Canon Corporation (Japan) • Boston Scientific Corporation (US) • Cordis (a Cardinal Health Company, US). • Shimadzu Corporation (Japan) • Medtronic (Ireland) • Angiodynamics (US) • B. Braun Melsungen (Germany) • Abbott Laboratories (US). • Toshiba Medical Systems Corporation • Terumo • Royal Philips Electronics • General Electric Company, • Abiomed • Aachen Resonance • Acrostak • AGA Medical • SHOCKWAVE Medical • Smiths Medical • Spectranetics • Vascular Closure Systems Research Methodology: Global Angiography Equipment Market is estimated by analysing the data points obtained from various sources and conducting them into a predictor model created specifically for each individual market. The data points are extracted from paid and unpaid sources along with paid primary interviews with key opinion leaders in the market. Key opinion leaders from both demand and supply sides of market were considered while conducting interviews to get unbiased idea of the market. This exercise was done at country level to get fair idea of the market in countries considered for this analysis. This country specific analysis was accumulated to establish regional numbers and then arrive at global market value for Global Angiography Equipment Market .
1. INTRODUCTION 1.1. Market description & Scope (2019-2026) 1.2. Objectives 1.2.1. Key Takeaways 1.2.2. Abbreviations & Acronyms 2. RESEARCH METHODOLOGY 2.1. Methods used for market forecasting 2.2. Data Products 2.2.1. Paid Databases 2.2.2. Primary Products 2.2.3. Secondary Products 3. EXECUTIVE SUMMARY 3.1. Major Findings 3.1.1. Key Segment Trends 3.1.1.1. Product 3.1.1.2. Application 3.1.1.3. Procedure 3.1.1.4. Technology 3.1.1.5. Indication 3.1.1.6. End Use 3.1.2. Key Regional Trends 3.1.2.1. North America 3.1.2.2. Europe 3.1.2.3. Asia Pacific 3.1.2.4. Rest of the World 3.2. Key Companies and their Strategies 4. MARKET OVERVIEW 4.1. Angiography Equipment Concept & Definition 4.2. Segments Overview 4.2.1. By Product 4.2.1.1. Angiography Equipment Solutions 4.2.1.1.1. Angiography Systems 4.2.1.1.2. Angiography Catheters 4.2.1.1.3. Angiography Contrast Media 4.2.1.1.4. Vascular Closure Devices (VCDs) 4.2.1.1.5. Angiography Balloons 4.2.1.1.6. Angiography Guidewires 4.2.1.1.7. Angiography Accessories 4.2.2. By Application 4.2.2.1. Diagnostics 4.2.2.2. Therapeutics 4.2.3. By End Use 4.2.3.1. Hospitals and Clinics 4.2.3.2. Diagnostic and Imaging Centers 4.2.3.3. Research Institutes 4.2.4. By Procedure 4.2.4.1. Coronary Angiography 4.2.4.2. Endovascular Angiography 4.2.4.3. Neuroangiography 4.2.4.4. Onco-angiography 4.2.4.5. Other Angiography Procedures 4.2.5. By Indication 4.2.5.1. Coronary Artery Disease 4.2.5.2. Valvular Heart Disease 4.2.5.3. Congenital Heart Disease 4.2.5.4. Congestive Heart Failure 4.2.5.5. Other Indications 4.2.6. Market Dynamics 4.2.6.1. Drivers 4.2.6.2. Restraints 4.2.6.3. Opportunities 4.3. Porter’s Analysis 4.4. PESTLE Analysis 4.5. Fragmentation 4.5.1. Key strategic Alliances of companies (inorganic & organic) 4.5.2. Company Market Share (Top 10 Players) 4.5.3. Comparative Analysis of Key players in Recycled Plastics 4.6. Key Trends 4.7. Key Trends in Global Angiography Equipment Market 5. GLOBAL ANGIOGRAPHY EQUIPMENT PRODUCT & TREND ANALYSIS (2019-2026) 5.1. Global Angiography Equipment Market Product Analysis 5.1.1. Angiography Equipment Solutions 5.1.1.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 6. GLOBAL ANGIOGRAPHY EQUIPMENT TECHNOLOGY & TREND ANALYSIS (2019-2026) 6.1. Global Angiography Equipment Technology Market Analysis 6.1.1. X-Ray Angiography 6.1.1.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 6.1.2. CT Angiography 6.1.2.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 6.1.3. MR Angiography 6.1.3.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 6.1.4. Other Angiography Technologies 6.1.4.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 7. GLOBAL ANGIOGRAPHY EQUIPMENT PROCEDURE & TREND ANALYSIS (2019-2026) 7.1. Global Angiography Equipment Procedure Market Analysis 7.1.1. Coronary Angiography 7.1.1.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 7.1.2. Endovascular Angiography 7.1.2.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 7.1.3. Neuroangiography 7.1.3.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 7.1.4. Onco-angiography 7.1.4.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 7.1.5. Other Angiography Procedures 7.1.5.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 8. GLOBAL ANGIOGRAPHY EQUIPMENT INDICATION & TREND ANALYSIS (2019-2026) 8.1. Global Angiography Equipment Indication Market Analysis 8.1.1. Coronary Artery Disease 8.1.1.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 8.1.2. Valvular Heart Disease 8.1.2.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 8.1.3. Congenital Heart Disease 8.1.3.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 8.1.4. Congestive Heart Failure 8.1.4.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 8.1.5. Other Indications 8.1.5.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 9. GLOBAL ANGIOGRAPHY EQUIPMENT APPLICATION & TREND ANALYSIS (2019-2026) 9.1. Global Angiography Equipment Application Market Analysis 9.1.1. Diagnostics 9.1.1.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 9.1.2. Therapeutics 9.1.2.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 10. GLOBAL ANGIOGRAPHY EQUIPMENT END USE & TREND ANALYSIS (2019-2026) 10.1. Global Angiography Equipment End Use Market Analysis 10.2. Hospitals and Clinics 10.2.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 10.3. Diagnostic and Imaging Centers 10.3.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 10.4. Research Institutes 10.4.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 11. REGIONAL ESTIMATES & TREND ANALYSIS (2019-2026) 11.1. Global Angiography Equipment market share by Region, 2016 & 2025 11.2. North America 11.2.1. North America Angiography Equipment market, Market Share and growth forecasts, 2019-2026 (USD Billion) 11.2.2. Angiography Equipment Drivers For North America Market 11.2.3. Market Share Analysis and Growth Forecast, by Country 11.2.3.1. US 11.2.3.2. Canada 11.2.4. Country-wise GDP Growth Forecast 11.2.5. Angiography Equipment Trends In North America Market 11.3. Europe 11.3.1. Europe Angiography Equipment market, Market Share and growth forecasts, 2019-2026 (USD Billion) 11.3.2. Angiography Equipment Drivers For Europe Market 11.3.3. Market Share Analysis and Growth Forecast, by Country 11.3.3.1. UK 11.3.3.2. Germany 11.3.3.3. France 11.3.3.4. Russia 11.3.3.5. Spain 11.3.3.6. Italy 11.3.3.7. Others 11.3.4. Country-wise GDP Growth Forecast 11.3.5. Angiography Equipment Trends In Europe Market 11.4. Asia Pacific 11.4.1. Asia Pacific Angiography Equipment market, Market Share and growth forecasts, 2019-2026 (USD Billion) 11.4.2. Angiography Equipment Drivers For Asia Pacific Market 11.4.3. Market Share Analysis and Growth Forecast, by Country 11.4.3.1. China 11.4.3.2. Japan 11.4.3.3. India 11.4.3.4. South Korea 11.4.3.5. Australia 11.4.3.6. Others 11.4.4. Country-wise GDP Growth Forecast 11.4.5. Angiography Equipment Trends In Asia Pacific Market 11.5. Rest of the World 11.5.1. Rest of the World Angiography Equipment market, Market Share and growth forecasts, 2019-2026 (USD Billion) 11.5.2. Angiography Equipment Drivers For Rest of the World Market 11.5.3. Market Share Analysis and Growth Forecast, by Country 11.5.3.1. Middle-East 11.5.3.2. Africa 11.5.3.3. Latin America 11.5.4. Country-wise GDP Growth Forecast 11.5.5. Angiography Equipment Trends In Rest of the World Market 12. MARKET SHARE ANALYSIS 12.1. Key Players Regional Market share Analysis 12.1.1. North America 12.1.2. Europe 12.1.3. Asia Pacific 12.1.4. Middle-east 12.1.5. Latin America 13. MARKET COMPETITION ANALYSIS 13.1. Strategy Framework 13.2. Consolidation 13.2.1. Patent Analysis 13.2.2. Mergers & Acquisitions 13.2.2.1. Product Based 13.2.2.2. Services Based 13.2.2.3. Region Based 13.2.2.4. List of Mergers & Acquisitions 13.2.3. Company Benchmarking (Revenue & Profit Based) 13.2.4. Strategic Assessment of Company Consolidations 13.2.5. Emerging Business Models 13.3. Company Profiles 13.3.1. GE Healthcare 13.3.1.1. Company overview 13.3.1.2. Key financials 13.3.1.3. Geographical presence 13.3.1.4. Product and Business Segments 13.3.1.5. Strategic initiatives 13.3.1.6. SWOT analysis 13.3.1.7. Competitive positioning and landscape 13.3.2. Koninklijke Philips N.V. 13.3.2.1. Company overview 13.3.2.2. Key financials 13.3.2.3. Geographical presence 13.3.2.4. Product and Business Segments 13.3.2.5. Strategic initiatives 13.3.2.6. SWOT analysis 13.3.2.7. Competitive positioning and landscape 13.3.3. Siemens Healthineers 13.3.3.1. Company overview 13.3.3.2. Key financials 13.3.3.3. Geographical presence 13.3.3.4. Product and Business Segments 13.3.3.5. Strategic initiatives 13.3.3.6. SWOT analysis 13.3.3.7. Competitive positioning and landscape 13.3.4. Canon Corporation 13.3.4.1. Company overview 13.3.4.2. Key financials 13.3.4.3. Geographical presence 13.3.4.4. Product and Business Segments 13.3.4.5. Strategic initiatives 13.3.4.6. SWOT analysis 13.3.4.7. Competitive positioning and landscape 13.3.5. Boston Scientific Corporation 13.3.5.1. Company overview 13.3.5.2. Key financials 13.3.5.3. Geographical presence 13.3.5.4. Product and Business Segments 13.3.5.5. Strategic initiatives 13.3.5.6. SWOT analysis 13.3.5.7. Competitive positioning and landscape 13.3.6. Cordis (a Cardinal Health Company 13.3.6.1. Company overview 13.3.6.2. Key financials 13.3.6.3. Geographical presence 13.3.6.4. Product and Business Segments 13.3.6.5. Strategic initiatives 13.3.6.6. SWOT analysis 13.3.6.7. Competitive positioning and landscape 13.3.7. Shimadzu Corporation 13.3.7.1. Company overview 13.3.7.2. Key financials 13.3.7.3. Geographical presence 13.3.7.4. Product and Business Segments 13.3.7.5. Strategic initiatives 13.3.7.6. SWOT analysis 13.3.7.7. Competitive positioning and landscape 13.3.8. Medtronic 13.3.8.1. Company overview 13.3.8.2. Key financials 13.3.8.3. Geographical presence 13.3.8.4. Product and Business Segments 13.3.8.5. Strategic initiatives 13.3.8.6. SWOT analysis 13.3.8.7. Competitive positioning and landscape 13.3.9. Angiodynamics (US) 13.3.9.1. Company overview 13.3.9.2. Key financials 13.3.9.3. Geographical presence 13.3.9.4. Product and Business Segments 13.3.9.5. Strategic initiatives 13.3.9.6. SWOT analysis 13.3.9.7. Competitive positioning and landscape 13.3.10. B. Braun Melsungen (Germany) 13.3.10.1. Company overview 13.3.10.2. Key financials 13.3.10.3. Geographical presence 13.3.10.4. Product and Business Segments 13.3.10.5. Strategic initiatives 13.3.10.6. SWOT analysis 13.3.10.7. Competitive positioning and landscape 13.3.11. Abbott Laboratories (US) 13.3.11.1. Company overview 13.3.11.2. Key financials 13.3.11.3. Geographical presence 13.3.11.4. Product and Business Segments 13.3.11.5. Strategic initiatives 13.3.11.6. SWOT analysis 13.3.11.7. Competitive positioning and landscape 13.3.12. Toshiba Medical Systems Corporation 13.3.13. Terumo 13.3.14. Royal Philips Electronics 13.3.15. General Electric Company, 13.3.16. Abiomed 13.3.17. Aachen Resonance 13.3.18. Acrostak 13.3.19. AGA Medical 13.3.20. SHOCKWAVE Medical 13.3.21. Smiths Medical 13.3.22. Spectranetics 13.3.23. Vascular Closure Systems

About This Report

Report ID10919
Category Healthcare
Published Dateoct 2019
Updated Dateoct 2020
Contact Us